TCL Archive In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB April 4, 1975
TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Funding Opportunities: Lustgarten Foundation Request For Proposals; RFAs Available; NCI Grant Supplements. June 20, 2003
TCL Archive NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration October 29, 1999